Evidence map›Paper›PMID 25374063›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

DNA repair gene polymorphisms and clinical outcome of patients with primary small cell carcinoma of the esophagus.

Qiang Zhou, Bing-Wen Zou, Yong Xu, Jian-Xin Xue, Mao-Bin Meng, Fang-Jiu Liu, Lei Deng, Dai-Yuan Ma, Rui Ao, You Lu

Open access · hybridAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Genetic Variations of DNA Repair Genes in Breast Cancer.Pathology oncology research : POR · 2019
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Qiang ZhouDepartment of Thoracic Oncology, Cancer Center and State Key Laboratory, West China Hospital, Medical School, Sichuan University, 37 Guoxue Lane, Chengdu, 610041, People's Republic of China.
Bing-Wen Zou
Yong Xu
Jian-Xin Xue
Mao-Bin Meng
Fang-Jiu Liu
Lei Deng
Dai-Yuan Ma
Rui Ao
You Lu
Sichuan University · CNAffiliated Hospital of North Sichuan Medical College · CNFourth People's Hospital of Sichuan Province · CNSuizhou Central Hospital · CNTianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphisms in DNA repair genes impact on the synthesis of DNA repair proteins that are crucial to the repair of DNA damages induced by chemotherapy and radiotherapy. We retrospectively examined whether there was an association between the selected six single nucleotide polymorphisms (SNPs) of five DNA repair genes (PARP1-Val762Ala, XRCC1-Arg194Trp, XRCC1-Arg399Gln, XPC-Lys939Gln, BRCA1-Lys1183Arg, and BRCA2-Asn372His) and the clinical outcome of patients with primary small cell carcinoma of esophagus (SCCE), and it showed that the median progression-free survival (PFS) and the overall survival (OS) were 11.8 versus 9.7 months (P = 0.041) and 17.4 versus 14.8 months (P = 0.032) for patients carrying the variant allele (T/C + C/C) and the wild-type allele (T/T) of PARP1-Val762Ala polymorphism, respectively. However, no statistical significance was observed in the other five polymorphic loci (P > 0.05). When these six SNPs were combined, however, patients with at least three variant genotypes had significantly longer PFS and OS compared with those carrying less than three variant genotypes (P = 0.009 and P = 0.007, respectively). The presence of at least three polymorphic variants in certain DNA repair genes may impact on patient survival and could be a potential genomic predictor of clinical response to DNA-damaging treatment in SCCE patients.

Indexed as

AllelesCarcinoma, Small CellDisease-Free SurvivalDNA DamageDNA RepairEsophageal NeoplasmsFemaleGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideRetrospective Studies

Identifiers

PMID25374063
PMCPMC4375303
OpenAlexW2095400124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.